about
Polycationic calixarene PTX013, a potent cytotoxic agent against tumors and drug resistant cancer.Unraveling galectin-1 as a novel therapeutic target for cancer.OTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors.OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis.Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
P50
description
onderzoeker
@nl
name
Lucile Astorgues-Xerri
@ast
Lucile Astorgues-Xerri
@en
Lucile Astorgues-Xerri
@es
Lucile Astorgues-Xerri
@nl
Lucile Astorgues-Xerri
@sl
type
label
Lucile Astorgues-Xerri
@ast
Lucile Astorgues-Xerri
@en
Lucile Astorgues-Xerri
@es
Lucile Astorgues-Xerri
@nl
Lucile Astorgues-Xerri
@sl
prefLabel
Lucile Astorgues-Xerri
@ast
Lucile Astorgues-Xerri
@en
Lucile Astorgues-Xerri
@es
Lucile Astorgues-Xerri
@nl
Lucile Astorgues-Xerri
@sl
P106
P21
P31
P569
2000-01-01T00:00:00Z